StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Allergan (AGN) says Darpin data does not support Phase 3 trials.
May 1, 2013 11:08 AM
UPDATE: Allergan, Inc. (NYSE:
AGN
) says Darpin data does not support Phase 3 trials. (halted on breaker)
Categories
FDA
Trader Talk
Trading Halts
Next Articles
Lazard Capital Upgrades Allergen (AGN) to Buy
May 2, 2013 7:11 AM
Morgan Stanley Downgrades Allergen (AGN) to Equalweight
May 1, 2013 2:31 PM
Allergan (AGN) Strong With or Without DARPin - RBC
May 1, 2013 12:02 PM
Allergan, Inc. (AGN) trading paused for volatility
May 1, 2013 11:06 AM